BioRegenx, Inc.
BRGX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$193.84K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $193,835.00 |
|---|---|
| Enterprise Value | $2.37 Million |
| Earnings per Share | $0 |
| Beta | -2.52 |
| Outstanding Shares | 969,173,181 |
Return
| Return on Equity | 28.74% |
|---|---|
| Return on Assets | -386.56% |
| Return on Invested Capital | 11.33% |
Valuation & Multiples
| P/E Ratio | -0.15 |
|---|---|
| PEG | 0.17 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.34 |
| Enterprise Value to EBIT | -5.73 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | -0.49 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioRegenx, Inc.
6 employees
CEO: William Resides
BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, t...